AustraliaResearchers discovered that a protein called osteopontin in breastmilk plays a crucial role in protecting infants from respiratory infections by stimulating immune system development. The study, led by immunologist Simon Phipps from the QIMR Berghofer Medical Research Institute, involved comparing the immune responses of baby mice fed breastmilk containing osteopontin versus those without it. The results showed that mice lacking osteopontin had fewer critical immune cells, while supplementation protected them from infection. The research also revealed that osteopontin alters gut microbiomes and activates immune pathways, with potential applications for improving infant formula. The study, published in the journal Cell, was partly funded by Nestlé and the Australian NHMRC.
Bias read (Center): The article presents scientific research without overt ideological framing. While the study involves potential implications for infant formula development, the focus remains on empirical findings and collaboration between researchers and industry. There is no clear partisan angle or emphasis on one側
